StreetInsider.com News Articles

Form 4 Instil Bio, Inc. For: Jun 11 Filed by: McGaughy R Kent Jr

Fri, 12 Jun 2026 14:40:00 -0400

si-local-file:///var/storage/secattach/20260612/26640159.html

Form 4 Instil Bio, Inc. For: Jun 11 Filed by: McGaughy R Kent Jr

Fri, 12 Jun 2026 14:40:00 -0400

si-local-file:///var/storage/secattach/20260612/26640159.html

Form 4 Instil Bio, Inc. For: Jun 11 Filed by: Matcham George

Fri, 12 Jun 2026 14:39:00 -0400

si-local-file:///var/storage/secattach/20260612/26640158.html

Form 4 Instil Bio, Inc. For: Jun 11 Filed by: Matcham George

Fri, 12 Jun 2026 14:39:00 -0400

si-local-file:///var/storage/secattach/20260612/26640158.html

Form 4 Instil Bio, Inc. For: Jun 11 Filed by: Gibson Neil W

Fri, 12 Jun 2026 14:38:00 -0400

si-local-file:///var/storage/secattach/20260612/26640157.html

Form 4 Instil Bio, Inc. For: Jun 11 Filed by: Gibson Neil W

Fri, 12 Jun 2026 14:38:00 -0400

si-local-file:///var/storage/secattach/20260612/26640157.html

Form 4 Instil Bio, Inc. For: Jun 11 Filed by: Binder Gwendolyn

Fri, 12 Jun 2026 14:37:00 -0400

si-local-file:///var/storage/secattach/20260612/26640151.html

Form 4 Instil Bio, Inc. For: Jun 11 Filed by: Binder Gwendolyn

Fri, 12 Jun 2026 14:37:00 -0400

si-local-file:///var/storage/secattach/20260612/26640151.html

Form 8-K Instil Bio, Inc. For: Jun 11

Thu, 11 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260611/26636204.html

Form 8-K Instil Bio, Inc. For: Jun 11

Thu, 11 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260611/26636204.html

Form 8-K Instil Bio, Inc. For: May 15

Fri, 15 May 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20260515/26500124.html

Form 8-K Instil Bio, Inc. For: May 15

Fri, 15 May 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20260515/26500124.html

Form 10-Q Instil Bio, Inc. For: Mar 31

Fri, 15 May 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20260515/26500138.html

Form 10-Q Instil Bio, Inc. For: Mar 31

Fri, 15 May 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20260515/26500138.html

Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

Fri, 15 May 2026 07:00:00 -0400

DALLAS, May 15, 2026 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a biotechnology company focused on identifying and advancing innovative therapeutics, today reported its first quarter 2026 financial results and provided a corporate update.

Recent Highlights

Instil is evaluating potential acquisitions and in-licensing that may provide access to promising novel therapeutic candidates
Cash position of approximately $74.7 million as of March 31, 2026 expected to fund current operating plan beyond 2027

“We continue to make progress refining Instil’s strategy and positioning the company for its next phase of growth,” said

Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

Fri, 15 May 2026 07:00:00 -0400

Recent Highlights

Instil is evaluating potential acquisitions and in-licensing that may provide access to promising novel therapeutic candidates
Cash position of approximately $74.7 million as of March 31, 2026 expected to fund current operating plan beyond 2027

“We continue to make progress refining Instil’s strategy and positioning the company for its next phase of growth,” said

Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

Fri, 15 May 2026 07:00:00 -0400

Recent Highlights

Instil is evaluating potential acquisitions and in-licensing that may provide access to promising novel therapeutic candidates
Cash position of approximately $74.7 million as of March 31, 2026 expected to fund current operating plan beyond 2027

“We continue to make progress refining Instil’s strategy and positioning the company for its next phase of growth,” said

Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

Fri, 15 May 2026 07:00:00 -0400

Recent Highlights

Instil is evaluating potential acquisitions and in-licensing that may provide access to promising novel therapeutic candidates
Cash position of approximately $74.7 million as of March 31, 2026 expected to fund current operating plan beyond 2027

“We continue to make progress refining Instil’s strategy and positioning the company for its next phase of growth,” said

Form ARS Instil Bio, Inc. For: Dec 31

Fri, 24 Apr 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260424/26366539.html

Form ARS Instil Bio, Inc. For: Dec 31

Fri, 24 Apr 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260424/26366539.html

Form DEFA14A Instil Bio, Inc.

Fri, 24 Apr 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260424/26366508.html

Form DEFA14A Instil Bio, Inc.

Fri, 24 Apr 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260424/26366508.html

Form DEF 14A Instil Bio, Inc. For: Jun 11

Fri, 24 Apr 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260424/26366476.html

Form DEF 14A Instil Bio, Inc. For: Jun 11

Fri, 24 Apr 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20260424/26366476.html

Form 8-K Instil Bio, Inc. For: Apr 01

Fri, 03 Apr 2026 08:01:00 -0400

si-local-file:///var/storage/secattach/20260403/26270172.html